Premark successfully closes fully subscribed seed finance round

Supported by investments from a consortium of US-based ophthalmologists and senior pharma industry executives, Premark has successfully completed a first round of financing. Sufficient funds have been generated to support business activities up to the commencement of the planned PMP2207 Phase 3 programme in blepharitis.